Study of outcomes in anti-LGI1 brain inflammation
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study follows people newly diagnosed with anti-LGI1 encephalitis (a brain inflammation) to see how well they do over time. It aims to learn more about the condition and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have anti-LGI1 encephalitis, a specific type of brain inflammation.
- You must be newly diagnosed and currently in the active (acute) phase of the illness.
- You must be willing to sign a consent form to participate.
- You cannot have had epilepsy, stroke, a brain injury, or other nervous system disease before this diagnosis.
- You cannot have other related antibodies, such as anti-CASPR2.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.
This study collects health information from people with autoimmune encephalitis, a condition where the body's immune system attacks the brain. It aims to understand the disease better, and if you have seizures from it, you can join a special epilepsy part.
This study looks at how the immune system works in certain neurological conditions, including autoimmune encephalitis and related nerve disorders. Researchers may use blood and/or spinal fluid samples, especially when antibodies are present or can’t be found, to better understand what’s driving the illness.
This study looks at how autoimmune encephalitis affects brain metabolism using a special PET scan. It aims to better understand the condition in people who were recently diagnosed.
This study tests a natural bile-derived medicine (Calcus Bovis Sativus) to see if it can help adults with new or recent brain inflammation (encephalitis). It focuses on people whose encephalitis is caused by the immune system or a virus, and who have not fully recovered.
This study is testing a new lab test that may help doctors more accurately diagnose GABABR antibody encephalitis, a type of brain inflammation. The test looks for certain antibodies in your blood or spinal fluid.
Hear when a new Autoimmune Encephalitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.